Evaluation of enzyme dose and dose-frequency in ameliorating substrate accumulation in MPS IIIA Huntaway dog brain. (Q48448348)

http://europepmc.org/abstract/MED/25421091

11 February 2018

title

Evaluation of enzyme dose and dose-frequency in ameliorating substrate accumulation in MPS IIIA Huntaway dog brain. (English)

1 reference

http://europepmc.org/abstract/MED/25421091

11 February 2018

author

Barbara King

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421091%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Marten F. Snel

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421091%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

8

Robert D Jolly

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421091%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Kim Hemsley

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421091%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

2

Neil Marshall

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421091%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

9

John J Hopwood

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421091%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

author name string

Helen Beard

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421091%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Sofia Hassiotis

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421091%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Paul J Trim

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421091%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Tina Rozaklis

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421091%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

publication date

25 November 2014

1 reference

http://europepmc.org/abstract/MED/25421091

11 February 2018

published in

Journal of Inherited Metabolic Disease

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421091%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421091%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

page(s)

341-350

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421091%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421091%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10545-014-9790-8

9 June 2020

exact match

0 references

cites work

Intrathecal recombinant human 4-sulfatase reduces accumulation of glycosaminoglycans in dura of mucopolysaccharidosis VI cats.

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9790-8

Differential expression of matrix metalloproteinases in the serum of patients with mucopolysaccharidoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9790-8

CNS penetration of intrathecal-lumbar idursulfase in the monkey, dog and mouse: implications for neurological outcomes of lysosomal storage disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9790-8

Metallothioneins as dynamic markers for brain disease in lysosomal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9790-8

Intraventricular enzyme replacement improves disease phenotypes in a mouse model of late infantile neuronal ceroid lipofuscinosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9790-8

Intrathecal enzyme replacement therapy: successful treatment of brain disease via the cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9790-8

Intracerebroventricular infusion of acid sphingomyelinase corrects CNS manifestations in a mouse model of Niemann-Pick A disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9790-8

Injection of recombinant human sulfamidase into the CSF via the cerebellomedullary cistern in MPS IIIA mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9790-8

Effect of high dose, repeated intra-cerebrospinal fluid injection of sulphamidase on neuropathology in mucopolysaccharidosis type IIIA mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9790-8

Examination of intravenous and intra-CSF protein delivery for treatment of neurological disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9790-8

Effect of cisternal sulfamidase delivery in MPS IIIA Huntaway dogs--a proof of principle study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9790-8

Intracisternal enzyme replacement therapy in lysosomal storage diseases: dispersal pathways, regional enzyme concentrations and the effect of posttreatment posture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9790-8

Secondary storage of dermatan sulfate in Sanfilippo disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9790-8

Allogeneic stem cell transplantation does not improve neurological deficits in mucopolysaccharidosis type IIIA mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9790-8

Single-dose intracerebroventricular administration of galactocerebrosidase improves survival in a mouse model of globoid cell leukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9790-8

Differential subcellular localization of cholesterol, gangliosides, and glycosaminoglycans in murine models of mucopolysaccharide storage disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9790-8

Prevalence of lysosomal storage disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9790-8

Amyloidosis, synucleinopathy, and prion encephalopathy in a neuropathic lysosomal storage disease: the CNS-biomarker potential of peripheral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9790-8

Cloning of the sulphamidase gene and identification of mutations in Sanfilippo A syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9790-8

Relative acidic compartment volume as a lysosomal storage disorder-associated biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9790-8

Sanfilippo syndrome: a mini-review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9790-8

Mucopolysaccharidosis type IIIA: clinical spectrum and genotype-phenotype correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9790-8

Biodistribution and pharmacodynamics of recombinant human alpha-L-iduronidase (rhIDU) in mucopolysaccharidosis type I-affected cats following multiple intrathecal administrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9790-8

Intrathecal tripeptidyl-peptidase 1 reduces lysosomal storage in a canine model of late infantile neuronal ceroid lipofuscinosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9790-8

Identification of a mutation causing mucopolysaccharidosis type IIIA in New Zealand Huntaway dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9790-8

Heparin cofactor II–thrombin complex: A biomarker of MPS disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-014-9790-8

Treatment of canine fucosidosis by intracisternal enzyme infusion

21 January 2018

1 reference

12 December 2020

Mucopolysaccharidosis IIIA (Sanfilippo syndrome) in a New Zealand Huntaway dog with ataxia

1 reference

12 December 2020

Repeated intrathecal injections of recombinant human 4-sulphatase remove dural storage in mature mucopolysaccharidosis VI cats primed with a short-course tolerisation regimen

1 reference

12 December 2020

Intrathecal enzyme replacement therapy reduces lysosomal storage in the brain and meninges of the canine model of MPS I

1 reference

12 December 2020

Intracerebroventricular enzyme infusion corrects central nervous system pathology and dysfunction in a mouse model of metachromatic leukodystrophy

1 reference

12 December 2020

A simple method for early age phenotype confirmation using toe tissue from a mouse model of MPS IIIA

1 reference

12 December 2020

Enzyme replacement reduces neuropathology in MPS IIIA dogs

1 reference

12 December 2020

Highly phosphomannosylated enzyme replacement therapy for GM2 gangliosidosis

1 reference

12 December 2020

Delivery of therapeutic protein for prevention of neurodegenerative changes: comparison of different CSF-delivery methods

1 reference

12 December 2020

Nonclinical evaluation of CNS-administered TPP1 enzyme replacement in canine CLN2 neuronal ceroid lipofuscinosis.

1 reference

12 December 2020

Intracisternal enzyme replacement therapy in lysosomal storage diseases: routes of absorption into brain

1 reference

12 December 2020

10.1007/S10545-014-9790-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421091%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

1 reference